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ABSTRACT
The cellular changes during an epithelial–mesenchymal transition
(EMT) largely rely on global changes in gene expression
orchestrated by transcription factors. Tead transcription factors
and their transcriptional co-activators Yap and Taz have been
previously implicated in promoting an EMT; however, their direct
transcriptional target genes and their functional role during EMT
have remained elusive. We have uncovered a previously
unanticipated role of the transcription factor Tead2 during EMT.
During EMT in mammary gland epithelial cells and breast cancer
cells, levels of Tead2 increase in the nucleus of cells, thereby
directing a predominant nuclear localization of its co-factors
Yap and Taz via the formation of Tead2–Yap–Taz complexes.
Genome-wide chromatin immunoprecipitation and next generation
sequencing in combination with gene expression profiling revealed
the transcriptional targets of Tead2 during EMT. Among these, zyxin
contributes to the migratory and invasive phenotype evoked by
Tead2. The results demonstrate that Tead transcription factors are
crucial regulators of the cellular distribution of Yap and Taz, and
together they control the expression of genes critical for EMT and
metastasis.
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INTRODUCTION
Epithelial–mesenchymal transition (EMT) is a cell-biological
program that is required at various stages of embryonic
development. Activation of EMT in epithelial cells induces
a loss of cell–cell adhesions and apical-basal polarity, and
promotes trans-differentiation into a mesenchymal state, which is
characterized by a migratory and invasive phenotype (Kalluri and
Weinberg, 2009; Nieto, 2011). During solid tumor progression, a
reactivation of some of these features in epithelial tumor cells
(oncogenic EMT) is regarded as one of the mechanisms that can
facilitate metastatic spread (Chaffer and Weinberg, 2011; Thiery
et al., 2009). Oncogenic EMT not only provides tumor cells with
invasive properties that permit dissemination from the primary
tumor, but also results in the acquisition of stem-cell-like traits,
which has implications for cancer therapy and might also be
important for colonization at distant organs (Chaffer and Weinberg,
2011; Magee et al., 2012; Polyak and Weinberg, 2009; Scheel and
Weinberg, 2012). Among the many genes and signaling pathways
active during EMT, transcription factors are the master coordinators
of the EMT program (Acloque et al., 2009; Moreno-Bueno et al.,
2008; Nieto, 2011).
The Hippo tumor suppressor signaling pathway plays a critical
role in restricting organ size by antagonizing the oncogenic
transcriptional co-activators Yap and Taz (Hong and Guan, 2012;
Zhao et al., 2011). A complex network of cell adhesion and signaling
molecules, including the tumor suppressor neurofibromin-2/
Merlin, regulates the Hippo kinase cascade, leading from the
protein kinases Mst1 and Mst2 via the protein kinases Lats1 and
Lats2 to the transcriptional co-factors Yap and Taz. When the
Hippo pathway is active, Yap and Taz are phosphorylated by
Lats1 and Lats2, and phosphorylated Yap and Taz are retained in
the cytoplasm. In the absence of activated Hippo signaling,
unphosphorylated Yap and Taz are imported into the nucleus
where they, together with Tead DNA-binding transcription
factors, activate the expression of proliferative and anti-
apoptotic genes.
In mammals, Tead transcription factors comprise a family of
four members (Tead1–Tead4). They are ubiquitously expressed
(Jacquemin et al., 1996; Kaneko and DePamphilis, 1998) and
exert partially redundant roles in regulating the development
of various embryonic tissues, including neural crest, whose
formation depends on EMT (Thiery et al., 2009), notochord and
trophectoderm (Milewski et al., 2004; Sawada et al., 2008;
Sawada et al., 2005; Yagi et al., 2007). Transcriptional activity
of the DNA-binding Teads requires their physical association
with the transcriptional co-activators Yap or Taz (Mahoney
et al., 2005; Vassilev et al., 2001). Upon Yap- or Taz-mediated
activation, Teads can exert multiple functions. For example, they
control proliferation in epithelial cells and fibroblasts (Ota and
Sasaki, 2008; Zhang et al., 2009; Zhao et al., 2008b). Moreover,
Yap and Taz are sufficient to induce EMT of MCF10A human
breast epithelial cells in a Tead-dependent manner (Lei et al.,
2008; Zhang et al., 2009; Zhao et al., 2008b), and the nuclear
accumulation of Yap and Taz in EpH4 murine mammary
epithelial cells is required for these cells to undergo TGFb-
induced EMT (Varelas et al., 2010b). Finally, elevated levels of
Yap trigger increased tumor growth and a pro-metastatic
phenotype through binding to Tead in breast cancer and
melanoma cells (Lamar et al., 2012). Even though these studies
clearly demonstrate a crucial role for Teads, Yap and Taz
in mediating EMT induction and cancer progression, the
mechanisms involved in the regulation of Tead transcriptional
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activity and the direct target genes during an EMT remain to be
identified.
To delineate the mechanisms underlying the transcriptional
activities of Teads and to identify their transcriptional target
genes during EMT, we have utilized cellular model systems of
EMT in non-transformed murine mammary gland epithelial cells
and in murine breast cancer cells. We report that the expression of
Tead family members is upregulated during EMT, concomitant
with an overall increase in Tead transcriptional activity. We
demonstrate that elevated levels of Tead2 lead to increased
nuclear localization of Yap and Taz, where they form a complex
with Tead2. As a result, increased Tead2 transcriptional activity
provokes the induction of EMT and a malignant tumor phenotype.
Conversely, knockdown of Teads in cells undergoing an EMT
prevents efficient subcellular redistribution of Yap and Taz and
blocks EMT. Genome-wide chromatin immunoprecipitation and
next generation sequencing (ChIP-Seq) in combination with gene
expression profiling identified several EMT-relevant genes as
direct transcriptional targets of Tead2 during EMT. Among these,
the gene encoding zyxin, a component of focal adhesions and an
actin cytoskeleton remodeling protein, is required for EMT-related
migration and invasion.
RESULTS
Formation of a nuclear Tead2–Yap–Taz complex and its
transcriptional activity during EMT
To identify crucial genes underlying the multiple stages of an EMT,
we induced EMT in the untransformed normal murine mammary
gland cell line NMuMG (Maeda et al., 2005) by treatment with
TGFb for 0, 1, 4, 7, 10 and 20 days (data not shown). During this
time course, the cells underwent progressive EMT and acquired a
complete mesenchymal morphology (Lehembre et al., 2008). Motif
Activity Response Analysis (MARA) (Suzuki et al., 2009) of gene
expression data derived from the EMT timecourse predicted
that several transcription-factor-binding motifs were important
regulators of the EMT expression dynamics, including a motif
bound by Tead transcription factors (supplementary material Fig.
S1A). This analysis suggested that genes that contain a species-
conserved Tead-binding MCAT motif are upregulated during an
EMT of NMuMG cells (supplementary material Fig. S1A).
To delineate the regulatory role of Tead transcription factors
in the EMT process, we utilized NMuMG cells and Py2T
murine breast cancer cells derived from a tumor of MMTV-
PyMT transgenic mice (Waldmeier et al., 2012), both of which
underwent EMT upon treatment with TGFb (Fig. 1A). MTflECad
cells have been established from a mammary tumor of a MMTV-
Neu transgenic mouse carrying conditional (floxed) alleles of the
E-cadherin gene (Cdh1). These cells undergo EMT upon Cre-
mediated genetic ablation of the E-cadherin gene (MTDECad)
(Lehembre et al., 2008) (Fig. 1A).
Gene expression profiling and quantitative RT-PCR revealed
that the transcripts of all four Tead family members could be
detected in the three model systems before, during and after
EMT, and that only Tead2 mRNA levels were upregulated across
all model systems analyzed (supplementary material Fig. S1B).
Based on the robust and reproducible expression of Tead2, we
chose to focus on Tead2 and generated polyclonal antibodies
specifically detecting Tead2 (supplementary material Fig. S1C–
E). Analysis of endogenous Tead2 expression levels in all three
EMT model systems by immunoblotting revealed that Tead2
protein levels increase upon EMT induction (Fig. 1B). EMT-
associated increased Tead2 expression was solely observed in
Py2T cells stimulated with TGFb, whereas other growth factors like
EGF, FGF, HGF, IGF, PDGF or IL-6 were not able to induce Tead2
expression (supplementary material Fig. S1F). Furthermore, small
interfering RNA (siRNA)-mediated ablation of Smad4 expression
during TGFb-induced EMT in NMuMG cells did not affect Tead2
expression levels, suggesting that TGFb-induced Tead2 expression
is independent of canonical TGFb signaling (supplementary
material Fig. S1G). Notably, siRNA-mediated ablation of Sox4
expression, a transcription factor known to be a crucial regulator
of EMT (Tiwari et al., 2013), revealed that Tead2 expression is
strictly dependent on Sox4 activity during TGFb-induced EMT in
NMuMG and Py2T cells (supplementary material Fig. S1H).
Immunofluorescence analysis showed that low levels of nuclear
Tead2 were present in epithelial cells, yet a much stronger nuclear
staining could be observed in cells that were in the process of
undergoing EMT (Fig. 1C, NMuMG and Py2T) or had undergone
EMT (Fig. 1C, MTDEcad). Immunofluorescence staining of the
Tead transcriptional co-activators Yap and Taz revealed that they
were distributed throughout the cytoplasm and in the nuclei of
epithelial cells, as expected in sparsely growing, proliferating cells
(Zhao et al., 2010) (Fig. 1C). Conversely, NMuMG and Py2T
cells undergoing TGFb-induced EMT or stably mesenchymal
MTDEcad cells displayed predominantly a nuclear localization of
Yap and Taz, highly similar to that of Tead2 (Fig. 1C).
We next investigated whether Tead2 binding to Yap and/or Taz
was subject to change during an EMT. Co-immunoprecipitation
experiments in total cell lysates (Fig. 1D, Py2T, NMuMG) or in
cytoplasmic and nuclear cell extracts (supplementary material
Fig. S1I) revealed that, indeed, the binding of Yap and Taz to
Tead2 increased exclusively in the nucleus upon TGFb stimula-
tion. Similarly, both Yap and Taz only bound to Tead2 in
mesenchymal MTDEcad cells and not in epithelial MTflEcad
cells (Fig. 1D, MT). From these data we conclude that formation
of a nuclear Tead2–Yap–Taz complex is increased during EMT,
even though total levels of Yap and Taz decrease upon EMT
induction (Fig. 1D; supplementary material Fig. S1I).
Consistent with these observations, we found that pan-Tead
transcriptional activity increased upon EMT induction in a Sox4-
dependent fashion (supplementary material Fig. S2A–C). Tead
transcriptional activity in cells undergoing EMT was assessed by
Tead-responsive luciferase reporter constructs bearing either
MCAT core motifs (CATTCCT; supplementary material Fig.
S2A) (Larkin et al., 1996) or GTIIC core motifs (ACATTCCAC;
supplementary material Fig. S2B) (Ota and Sasaki, 2008). In
addition, the transcriptional activity of a previously described
Cyr61 promoter reporter containing a Tead-responsive MCAT
motif (Lai et al., 2011) was induced during EMT of NMuMG cells,
whereas mutation of the Tead-binding site resulted in a complete
loss of the reporter activity (supplementary material Fig. S2D).
Taken together, these data demonstrate that, upon EMT
induction, Tead2 expression levels are increased in a Sox4-
dependent manner concomitant with enhanced formation of the
Tead2–Yap–Taz complex in the nucleus. In accordance with
these observations, overall Tead transcriptional activity increases
during EMT.
Nuclear localization of Yap and Taz is mediated by Tead2 and
is required for EMT
From the data presented above, we hypothesized that binding of
the increased levels of Tead2 to Yap and Taz in the nucleus
is required to activate Tead2-mediated transcriptional activity
during EMT. To test this hypothesis, we first investigated whether
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Fig. 1. See next page for legend.
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overexpression of Tead2 in epithelial cells can provoke a
subcellular redistribution of Yap and Taz. Immunofluorescence
microscopy analysis revealed that Yap and Taz were evenly
distributed between the cytoplasm and nucleus in control cells
(Fig. 2A, Vector) or in cells transfected to express a Tead2
mutant (Fig. 2A, Tead2 Y440H), which is incapable of binding to
Yap or Taz (Fig. 2A) (Chen et al., 2010; Kitagawa, 2007; Li
et al., 2010; Tian et al., 2010; Zhao et al., 2008b). Conversely, the
forced expression of wild-type Tead2 (Tead2-WT) in NMuMG
cells resulted in a marked concentration of Yap and Taz in the
nucleus and reduced levels of cytoplasmic Yap and Taz, suggesting
that Tead2 controls Yap and Taz subcellular distribution by direct
binding. Consistent with these observations, Tead transcriptional
activity was increased by the expression of wild-type Tead2 but
not by the expression of mutant Tead2 Y440H (supplementary
material Fig. S3A).
We next assessed whether upregulation of Teads during EMT
is required for Yap and Taz redistribution and for EMT. NMuMG
cells were transfected with control siRNA (siCtr) or with
siRNAs against Tead1, 2 and 3 (siTead1-3) whose expression
were upregulated during EMT in these cells (supplementary
material Fig. S1B). As expected, TGFb-treated cells transfected
with control siRNA displayed predominantly nuclear localized
Yap and Taz in response to TGFb-treatment, whereas knockdown
of Teads prevented this subcellular redistribution (Fig. 2B).
Importantly, depletion of Teads and the resulting failure of Yap
and Taz subcellular redistribution also averted the disassembly
of tight junctions and adherens junctions normally observed during
EMT (supplementary material Fig. S3B). Moreover, immunoblot-
ting analysis of EMT marker expression revealed an attenuation of
EMT upon Tead ablation: downregulation of E-cadherin was
inhibited and, conversely, upregulation of the mesenchymal
markers fibronectin and N-cadherin were delayed (supplementary
material Fig. S3C). Similarly, blocking Tead transcriptional
activity by the inducible expression of a dominant-negative version
of Tead2 (Tead2-EnR) attenuated the EMT process in TGFb-
treated Py2T cells (supplementary material Fig. S3D,E). These
results indicate that Teads are crucial for regulating the
cytoplasmic-nuclear redistribution of Yap and Taz during EMT
and that this regulatory process is required for EMT.
We next asked whether experimentally increasing Tead2 levels
and transcriptional activity in epithelial cells is sufficient to
induce EMT. We generated Py2T cells that expressed wild-type
Tead2 under the control of the doxycycline-inducible system.
Treatment with doxycycline for 3 days led to a heterogeneous
induction of Tead2 expression in these cells (Fig. 2C). Non-
induced cells expressing low endogenous levels of Tead2 showed
Yap and Taz staining in the cytoplasm as well as in the nucleus.
In doxycycline-treated cells, the elevated levels of nuclear Tead2
resulted in concentration of Yap and Taz in the nucleus (Fig. 2C).
By 3 days after doxycycline induction, Tead2-expressing
cells had already started to lose E-cadherin expression; this
phenotype was enforced with a prolonged doxycycline treatment
(supplementary material Fig. S3F), indicating that the elevation
of Tead2 levels was sufficient to induce EMT.
Yap and Taz nuclear localization, increased formation of Yap–
Taz–Tead2 complexes and heightened Tead transcriptional
activity was also observed in Py2T cells stably expressing wild-
type Tead2 (Tead2-WT) (supplementary material Fig. S3G,H)
(Ota and Sasaki, 2008). Notably, although overexpression of a
constitutively active version of Tead2 (Tead2-VP16) lacking a
Yap- and Taz-binding site showed a transcriptional activity that
was highly dependent on Tead (mediated by the Herpes simplex
virus VP16 transactivation domain), but no increased nuclear
localization of Yap and Taz (supplementary material Fig. S3G,I).
Furthermore, forced expression of both wild-type Tead2 and
constitutively active Tead2-VP16 also resulted in the morpholo-
gical changes consistent with EMT [i.e. the loss of the epithelial
markers E-cadherin and ZO-1, increased expression of the
mesenchymal markers vimentin, Zeb1/2 and Slug, and a shift
of the cytoskeleton from displaying cortical actin to actin stress
fibers (Fig. 2D; supplementary material Fig. S3J)]. Transient
siRNA-mediated ablation of Yap or Taz in Tead2-WT (siYap and
siTaz, respectively) cells led to a mesenchymal-to-epithelial
transition (MET), as indicated by an epithelial morphology
and the increased expression of E-cadherin in Yap- or Taz-
deficient cells (Fig. 2E,F). Collectively, these results demonstrate
that Tead2 is able to induce an EMT via the formation of
transcriptionally active complexes with Yap and Taz.
Tead2 promotes tumor cell migration, invasion and
metastasis
A hallmark of cells undergoing EMT is the acquisition of
migratory and invasive properties (Nieto, 2011; Yilmaz and
Christofori, 2009). Consistent with their mesenchymal phenotype,
cells expressing Tead2-WT exhibited an increased capability to
migrate and to invade (Fig. 3A). In contrast to control cells,
which formed smooth spheres, Tead2-WT and Tead2-VP16 cells
invaded there-dimensional Matrigel and projected filopodia into
the extracellular matrix (Fig. 3B). These results indicate that,
consistent with its EMT-inducing activities, Tead2 also promotes
cancer cell migration and invasion.
We next assessed whether Tead2-induced EMT, cell migration
and cell invasion translated into a higher metastatic capability in
Py2T murine breast cancer cells. Py2T cells stably expressing
Tead2-WT, Tead2-VP16 or a control vector were injected into the
tail veins of Balb/c nu/nu immune-deficient mice, and the
formation of lung metastasis was scored 33 days after injection.
Serial sectioning of paraffin-embedded lungs and staining by
hematoxylin and eosin revealed that only one out of six mice
injected with epithelial control cells displayed macroscopically
visible tumor cell clusters. Notably, these nodules were found
encapsulated within blood vessels (Fig. 3C,D). In contrast, half
of the mice injected with Tead2-WT cells and five out of six
mice injected with Tead2-VP16 cells developed macroscopic
metastases (Fig. 3C,D), with a higher incidence per mouse as
compared to control cells (Fig. 3E).
Fig. 1. Tead2 upregulation and Yap and Taz subcellular redistribution
during EMT. (A) Morphological differences between epithelial and
mesenchymal counterparts of the three different cellular EMT model systems
used. Epithelial NMuMG and Py2T cells were treated with TGFb for 13 days
to induce EMT. Stably mesenchymal MTDEcad cells were derived from
epithelial MTflEcad cells by Cre-recombinase-mediated knockout of the E-
cadherin gene. Scale bars: 50 mm. (B) Immunoblotting analysis of Tead2 and
E-cadherin expression levels before, during and after TGFb-induced EMT in
NMuMG and Py2T cells, and by genetic deletion in MTflEcad cells. Actin
served as a loading control. (C) Immunofluorescence staining of Tead2 and
its co-factors Yap and Taz before and after induction of EMT. Yap and Taz
were stained with an antibody that detects both proteins. E-cadherin staining
served as a control, DAPI was used to visualize nuclei. Scale bar: 25 mm.
(D) Interaction of Tead2 with Yap and Taz. Cells were treated with TGFb for 4
days (NMuMG) or 7 days (Py2T). Co-immunoprecipitation (IP) was
performed with an antibody against Tead2 or irrelevant IgG as a negative
control. Levels of Yap, Taz and Tead2 were determined by immunoblotting
analysis. Gapdh served as loading control.
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Fig. 2. See next page for legend.
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Taken together, these results indicate that Tead2 promotes
increased cancer cell migration/invasion and metastatic
outgrowth of Py2T cells in the lung.
The transcriptional Tead2 target genes during EMT
The results presented above suggest that Tead2 function is
regulated differently during EMT, leading to a malignant cancer
cell phenotype. To elucidate the corresponding downstream
mechanisms we sought to identify genes that are transcriptionally
regulated by Tead2 during the process of EMT. Using our
Tead2 antibody we performed chromatin immunoprecipitation
followed by next generation sequencing (ChIP-Seq) at 5
days of TGFb-treatment, a time point at which Tead2
expression and activity was robustly increased in Py2T cells
(Fig. 1B; supplementary material Fig. S2A). Detection of
known overrepresented transcription factor binding motifs by
Hypergeometric Optimization Motif EnRichment (HOMER)
revealed that the MCAT Tead-binding motif (supplementary
material Fig. S1A) is the most significant motif found in Tead2
bound regions, followed by a motif bound by Jun-AP1 (Fig. 4A).
PhyloGibbs, an algorithm that de novo infers overrepresented and
evolutionarily conserved sequence motifs from ChIP-Seq data,
Fig. 2. Elevated Tead2 levels induce a predominant nuclear localization of
Yap and Taz and induce EMT. (A) Yap and Taz cellular localization is
dependent on their direct binding to Tead2. A vector control (Vector), wild-type
Tead2 (Tead2-WT) or a Tead2 point mutant defective in Yap and Taz binding
(Tead2 Y440H) were stably expressed in NMuMG cells, and Yap and Taz and
Tead2 localization was assessed by immunofluorescence staining. DAPI was
used to visualize nuclei. Scale bar: 20 mm. (B) Depletion of Tead expression
prevents the reduction in cytoplasmic levels of Yap and Taz during EMT.
NMuMG cells transfected or not with siRNA pools targeting Tead1-3 were
induced to undergo EMT by TGFb-treatment for 4 days. Yap and Taz, and
Tead2 were visualized as described in A. Scale bar: 25 mm. (C) Effect of acute
Tead2 overexpression on Yap and Taz localization and epithelial differentiation.
Tead2 was expressed in Py2T cells (Py2T-iTead2) in a doxycycline (Dox)-
inducible fashion, and the localization of Tead2, Yap and Taz and E-cadherin
were visualized by an immunofluorescence staining. Scale bar: 20 mm.
(D) Effect of Tead2 gain-of-function on cell morphology and EMT. Py2T cells
were stably transduced with constructs coding for Tead2 (Tead2-WT), a
constitutively active version of Tead2 (Tead2-VP16) or an empty vector control.
Overall morphological changes were visualized by phase-contrast microscopy
and by immunofluorescence staining against E-cadherin, ZO-1, vimentin and
the actin cytoskeleton (phalloidin staining). The insets show an enlarged view of
F-actin staining. Scale bars: 15 mm. (E,F) Depletion of Yap or Taz expression
prevents Tead2-induced EMT. Py2T cells stably overexpressing Tead2 were
transfectedwith siRNApools against Yap and Taz or with a control siRNA (siCtr).
Overall cell morphology by phase-contrast microscopy (E) and immunoblotting
analysis of E-cadherin, Yap and Tazexpression (F) are shown. Scale bar: 15 mm.
Fig. 3. Tead2 promotes cell migration, invasion and metastasis. (A) Chemotactic migration and invasion of Py2Tcells stably expressing Tead2-WTor an empty
vector control. Transwell assays were performed utilizing cell culture inserts that were not coated (migration) or coated with Matrigel (invasion). Migrated and invaded
cells were quantified. Data are shown as mean 6 s.e.m. (n53; **P,0.01). (B) Cell invasion in a 3D extracellular matrix. Py2T cells stably expressing Tead2-
WTor Tead2-VP16 were embedded in Matrigel and allowed to grow for 5 days. Empty-vector-transduced Py2T cells served as a control. Scale bars: 50 mm.
(C) Experimental metastasis. Py2Tcells as described in Bwere injected into the tail veins of female Balb/c nu/numice. Mice were killed 33 days post-injection and lungs
were sectioned and stained by hematoxilin and eosin (H&E). Higher magnifications are also shown (right). Scale bars: 100 mm. (D,E) Quantification of lungmetastasis
incidence and number of lung metastasis per mouse as determined by serial sectioning and microscopic analysis of lungs as described in C. The metastatic
incidence was calculated as mice harboring metastases/total number of mice per group. Data are shown as mean6s.e.m. (n56 mice per group; *P,0.05).
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Fig. 4. See next page for legend.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 1523–1536 doi:10.1242/jcs.139865
1529
Jo
ur
na
l o
f C
el
l S
ci
en
ce
also revealed a motif that corresponds to the MCAT and to the
highly similar GTIIC core Tead binding motifs (Fig. 4B). These
findings suggest that the known MCAT and GTIIC motifs are
among the main sequence motifs targeted by Tead2 during
TGFb-induced EMT.
To identify direct target genes of Tead2 that showed a change
in their expression during EMT, we performed genome-wide
gene expression profiling in epithelial Py2T cells and in Py2T
cells treated with TGFb for 5 days. Genes that had a different
expression level, passing a cutoff of at least 1.5-fold (adjusted
P,0.05), were selected for an overlay with Tead2-bound genes as
determined by ChIP-Seq analysis (Fig. 4C; supplementary
material Table S1). Tead2-bound genes were defined as
showing a ChIP-Seq peak at a distance less than 10 kb to their
transcriptional start sites (TSS). The overlay analysis identified
132 genes bound by Tead2 in their promoter regions and showing
increased or decreased expression during TGFb-induced EMT
(supplementary material Table S2). Gene ontology analysis
for cellular components by GOstats (Ikeda et al., 2009) revealed
that Tead2 predominantly controls genes which encode for
components of cell junctions and regulators of the actin
cytoskeleton (Fig. 4D).
Among these 132 genes, we validated known Tead target genes
by ChIP-PCR, including Ctgf and Cyr61 (Zhang et al., 2011), whose
expression also increased upon TGFb-stimulation in the three EMT
model systems investigated (Fig. 4E,F; supplementary material Fig.
S4A,B). Furthermore, we identified other candidate Tead2 target
genes that had been previously implicated in EMT and/or malignant
tumor progression (De Craene and Berx, 2013; Polyak and
Weinberg, 2009; Tiwari et al., 2012), such as Amotl2, Esrp2, Mal,
Pdfgc, Serpine1 and others (supplementary material Table S2). We
further ascertained that Pard6b, a gene encoding for a polarity
complex protein, and Elmo3, a gene implicated in phagocytosis and
cell migration, were Tead2 target gene candidates. The expression of
these genes was decreased during TGFb-induced EMT in Py2T and
mesenchymal MTDEcad cells, indicating that Tead2 is not
exclusively a transcriptional activator but also a repressor of gene
expression (Fig. 4E,F; supplementary material Fig. S4B).
Given that, during EMT, Tead2 formed nuclear complexes
with Yap and Taz (Fig. 1D; supplementary material Fig. S1I),
we assessed whether some of the above-mentioned Tead2-
regulated genes were bound by a Tead2–Yap–Taz complex. ChIP
experiments for Tead2, Yap and Taz in Py2T cells induced to
undergo EMT and subsequent RT-PCR analysis revealed similar
or increased binding of Yap and/or Taz to the same promoter
regions targeted by Tead2, including the promoters of Ctgf
Cyr61, Pard6b, Elmo3 and Pdgfc (supplementary material Fig.
S4C).
These results indicate that the Tead2–Yap–Taz complex
regulates EMT-relevant genes by acting as a transcriptional
activator or repressor, mainly by binding to promoter sequences
containing Tead-specific MCAT or GTIIC motifs.
Zyxin is a Tead2–Taz target gene critical for EMT
ChIP-Seq also revealed a direct binding of Tead2 to an intronic
region of the gene encoding for zyxin (Zyx; supplementary
material Fig. S4D). Close inspection of this region revealed the
presence of a species-conserved MCAT motif (Fig. 5A). Zyxin is
an actin regulatory protein that localizes to sites of focal
adhesions and stress fibers in response to mechanical cues to
facilitate actin polymerization and generation of traction force
(Beckerle, 1997; Hirata et al., 2008; Smith et al., 2010). In line
with this functional role, zyxin upregulation during EMT in
NMuMG cells has been reported to be essential for cell migration
(Mori et al., 2009), and given that forced expression of Tead2
promotes cancer cell migration or invasion, and metastatic
outgrowth of Py2T cells in the lung (Fig. 4), we decided to
focus on zyxin as a Tead2 target gene.
ChIP-PCR on Py2T cells treated with TGFb for 5 days
confirmed the binding of endogenous Tead2 to an intronic region
of the Zyx gene (Fig. 5B). Concomitantly, mRNA and protein
levels of zyxin were substantially increased during EMT in Py2T
cells (Fig. 5C). Higher zyxin expression was also found in
mesenchymal MTDEcad cells as compared to MTflEcad cells
(supplementary material Fig. S4E). Immunofluorescence micro-
scopy analysis confirmed increased levels of zyxin localized
along stress fibers that are formed during TGFb-induced EMT in
Py2T cells and at focal adhesion sites (Fig. 5D), as previously
reported (Mori et al., 2009).
To evaluate whether increased expression of zyxin during
EMT is dependent on Tead activity, we induced EMT in a
pool of Py2T cells expressing a dominant-negative version of
Tead2 (Tead2-EnR) under the control of the doxycycline-
inducible system. Immunoblotting and RT-PCR analysis
demonstrated that expression of Tead2-EnR significantly
attenuated zyxin upregulation during EMT (Fig. 5E,F). Similarly,
siRNA-mediated knockdown of Tead1, 2 and 3 in NMuMG cells
and knockdown of Taz, not Yap, in Py2T cells prevented increased
expression of zyxin during EMT (Fig. 5G,H).
We next assessed whether zyxin expression was indeed
controlled by Tead2. We thus evaluated zyxin expression in
response to modulating Tead2 function by the expression
of wild-type Tead2 and Tead2-VP16, by the expression of
wild-type Yap and Taz and by the expression of Hippo-
signaling-insensitive mutant versions of Yap and Taz (Pan,
2010). Immunoblotting analysis revealed that zyxin expression
was induced by forced expression of Tead2-WT, Tead2-VP16
and both versions of Taz, but not by Yap (Fig. 5I,J). These
results demonstrate that Tead2 mediates Zyx gene expression via
Taz co-activation.
Fig. 4. Identification of direct Tead2 transcriptional target genes during
EMT. (A) DNA-binding motifs that are overrepresented in Tead2-binding
regions. Py2T cells treated with TGFb for 5 days were subjected to ChIP
using an antibody for Tead2 followed by next generation sequencing (ChIP-
Seq; n52). The sequencing data were subjected to Hypergeometric
Optimization of Motif EnRichment analysis (HOMER). Shown are the motifs
that are significantly enriched. (B) De novo generation of sequence motifs
overrepresented in Tead2-binding regions using PhyloGibbs. Shown is the
most significant Tead2-binding motif. (C) Determination of potential direct
target genes of Tead2 during EMT. The Venn diagram depicts the number of
genes from the Tead2 ChIP-Seq analysis, the number of genes that were
regulated differently in Py2T cells before and after 5 days of TGFb treatment
and the number of overlapping genes. (D) Gene ontology analysis was
performed on overlapping genes described in C using GOstats. The table
shows the functional annotation clustering analysis for the top five cellular
compartments, the associated genes per group and their P-values within the
groups. (E) Validation of genes directly bound by Tead2 by quantitative PCR.
Chromatin from the cells treated as described in A was subjected to qPCR
using primer pairs spanning the Tead2-binding regions determined by
ChIP-Seq. The data are presented as fold enrichment above background (IP
over input) and were normalized to control IgG. An intergenic region was
used as negative control. Data are represented as means6s.e.m. (n52).
(F) Expression of Tead2-bound genes during EMT as determined by RT-
qPCR. Py2T and NMuMG cells were treated with TGFb for 5 or 4 days,
respectively. Fold changes in mRNA expression are presented as
means6s.e.m. (n53). *P,0.05, **P,0.01, ****P,0.0001.
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Fig. 5. See next page for legend.
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To determine the functional contribution of increased zyxin
expression levels to cell migration and invasion, we tested
whether the increased migratory and invasive phenotype of Py2T
cells treated with TGFb (.20 days) or of Py2T cells forced to
express Tead2-WT (Fig. 3A) could be reversed by siRNA-
mediated ablation of zyxin expression (supplementary material
Fig. S4G). Indeed, knockdown of zyxin in cells expressing wild-
type Tead2 or cells treated with TGFb led to a reduction in cell
migration and invasion (Fig. 5K). Interestingly, knockdown of
zyxin in Py2T cells overexpressing wild-type Tead2 had no effect
on the mesenchymal morphology of these cells (supplementary
material Fig. S4H), indicating that zyxin is only required for cell
migration and invasion and not for the morphogenic process of
EMT. The results demonstrate that Tead2 directly regulates zyxin
expression during TGFb-induced EMT via its co-factor Taz and
thereby induces a zyxin-driven migratory and invasive cell
phenotype.
DISCUSSION
The transdifferentiation of epithelial cells into a mesenchymal
state involves a thorough remodeling of cell architecture, such as
the loss of apical-basal cell polarity accompanied by a breakdown
of tight and adherens junctions. Concomitantly, the establishment
of mesenchymal traits involves the generation of front–rear
polarity via remodeling of the actin cytoskeleton and the
activation of cell migration. These changes largely rely on
global changes in gene expression orchestrated by transcription
factors (Sa´nchez-Tillo´ et al., 2012). Here, we have uncovered a
crucial mechanistic role of Tead transcription factors, in
particular Tead2, during the process of EMT.
We demonstrate that Tead2 expression is increased during
EMT and that elevated nuclear levels of Tead2 lead to nuclear
complex formation with Yap and Taz and to increased
nuclear localization of these cofactors. We further demonstrate
that increased Tead2 expression during EMT is accompanied
by enhanced Tead2-mediated transcriptional activity. Notably,
experimental elevation of Tead2 transcriptional activity is
sufficient to induce an EMT and the establishment of lung
metastasis. The EMT-associated upregulated expression of Tead2
is independent of canonical TGFb signaling, because the ablation
of Smad4 during TGFb-induced EMT had no substantial impact
on Tead2 expression. Moreover, our studies indicate that the
Tead2 gene is a downstream target of the transcription factor
Sox4, a crucial epigenetic regulator of EMT (Tiwari et al., 2013).
Whether Tead2 gene expression is directly activated by Sox4
during EMT remains to be addressed. Recent studies on
SoxC family members, which include Sox4, Sox11 and Sox12,
demonstrate a direct regulation of the Tead2 gene promoter by
Sox4 and Sox11 in the fibroblast-like cell line Cos-1 (Bhattaram
et al., 2010). Given that Sox4 controls the levels of Tead2, which
are crucial for Tead2 binding to the Hippo downstream targets
Yap and Taz in nucleus, it will be interesting to assess whether
Sox4 is an integrator of non-canonical TGFb signaling and Hippo
signaling.
Several recent studies have suggested that elevated Tead
activity mediated by a gain-of-function of Yap or Taz can evoke a
malignant phenotype. Indeed, Taz is highly expressed in ,20%
of breast cancers, most of which represent invasive ductal
carcinomas (IDCs), and expression of this Tead co-activator is
responsible for migration and invasiveness of cultured breast
cancer cell lines (Chan et al., 2008). Recently, another study
has demonstrated that overexpression of a Hippo-signaling-
insensitive version of Yap (YapS127A) renders breast cancer
and melanoma cells pro-metastatic (Lamar et al., 2012). In
accordance with our results, this effect depends on an intact
interaction domain for Yap in Tead, and Tead transcriptional
activity correlates with the metastatic potential of various cancer
cell lines. Our results are also consistent with previous
reports demonstrating that ectopic expression of Yap and Taz
in MCF10A normal breast epithelial cells induces EMT via Tead
transcriptional activity (Lei et al., 2008; Zhao et al., 2008b).
As expected from cells that have undergone an EMT, we
report that Tead2-overexpressing cells display increased
migration, invasion and metastasis in comparison to control
cells. Conversely, an attenuation of TGFb-induced EMT is
observed when a dominant-negative version of Tead2 (Tead2-
EnR) is expressed. This effect is also observed upon siRNA-
mediated depletion of Tead family members. These results
demonstrate that the presence and transcriptional activity of
Teads is required for the proper execution of a TGFb-induced
EMT program.
Tead transcriptional activity is mainly controlled by the direct
binding of the co-factors Yap and Taz (Mahoney et al., 2005;
Vassilev et al., 2001; Zhang et al., 2009; Zhao et al., 2008a).
Here, we have investigated whether this is also true during EMT
in normal mammary epithelial cells and in breast cancer cells. In
epithelial cells, Yap and Taz are almost equally distributed
between the cytoplasm and the nucleus. However, during EMT
Yap and Taz are predominantly localized to the nucleus and this
subcellular redistribution is dependent on their binding to Tead2.
Fig. 5. Zyxin is a direct Tead2 target gene critical for cell migration.
(A) Top: scheme of the zyxin gene (Zyx) showing the location of the Tead2-
binding site (red). Arrows denote primers used in B. Middle: species
conservation of the Tead2-binding region. The red box denotes the core
MCAT motif. Bottom: mammalian conservation plot encompassing 32
species (derived from UCSC genome browser). (B) Validation of Tead2-
binding to the Zyx gene by ChIP-qPCR in Py2T cells treated with TGFb for 5
days. The qPCR data (n53; mean 6 s.e.m.; *P,0.05) indicate fold
enrichment above background and were normalized to irrelevant IgG as
negative control. (C) Zyxin expression during EMT. Py2T cells were treated
with TGFb for the indicated durations. Regulation of mRNA (top) and protein
level (bottom) was determined by RT-qPCR and immunoblotting analysis.
Results are presented as means6s.e.m. (n53). *P,0.05; **P,0.01.
(D) Immunofluorescence staining of zyxin and F-actin in epithelial and
mesenchymal Py2T cells. Cells were treated with TGFb as indicated. F-actin
was stained with phalloidin coupled to a fluorophore. Scale bar: 15 mm.
(E,F) Zyxin protein and mRNA levels in Py2T cells undergoing EMT without
(2) or with (+) doxycycline (Dox)-induced expression of a HA-tagged
dominant-negative version of Tead2 (Tead2-EnR) before and during a TGFb-
induced EMT. Results are presented as means6s.e.m. (n52). **P,0.01.
(G) Immunoblotting analysis of zyxin during TGFb-induced EMT of NMuMG
cells transfected with siRNA pools targeting Tead1, 2 and 3 or control siRNA.
Membranes shown in supplementary material Fig. S3C were reprobed
with an antibody against zyxin. (H) Yap, Taz and zyxin mRNA expression
levels in Py2T cells. Cells were transfected with siRNA pools against Yap,
Taz or a control siRNA and cultured in the absence and presence of TGFb.
Results are presented as means6s.e.m. (n52). *P,0.05, **P,0.01,
***P,0.001. (I,J) Immunoblotting analysis of zyxin expression in Py2T cells
overexpressing HA-tagged wild-type Tead2 (HA–Tead2-WT), constitutively
active Tead2 (HA–Tead2-VP16), and wild-type or Yap and Taz mutants (HA–
TazS89A, HA–YapS127A). (K) Contribution of zyxin to mesenchymal
migration and invasion induced by Tead2 overexpression (Tead2-WT; left
panel) or by 20 day TGFb-treatment (right panel). Py2T cells were
transfected with siRNA pools against zyxin or control siRNA pools and
subjected to chemotactic transwell migration and invasion assays as
described in Fig. 3A. Data are represented as means6s.e.m. (n53).
*P,0.05, **P,0.01.
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We also observe a membranous staining pattern of Yap and Taz
in epithelial cells reminiscent of tight junctions (data not shown).
This observation is consistent with a series of studies reporting
that Yap and Taz clusters with apical junction proteins, such as
Crumbs, PATJ, PALS, angiomotins and a-catenin, thereby
counteracting their nuclear entry (Chan et al., 2011; Silvis
et al., 2011; Varelas et al., 2010a; Varelas et al., 2010b; Wang
et al., 2011; Zhao et al., 2011). On the basis of published
observations and our own results, it is tempting to speculate that,
in epithelial cells, membrane-bound Yap and Taz are released by
EMT-induced disassembly of junctional complexes, and
increased nuclear levels of a Tead2–Yap–Taz complex in the
nucleus to finally promote Tead transcriptional activity.
To the best of our knowledge, this is the first report on
genes that are transcriptionally regulated by activated Tead2
during EMT. ChIP-Seq analysis has identified genes that
are directly bound by Tead2 during TGFb-induced EMT
(supplementary material Table S1). Our results indicate that in
cells undergoing EMT, Tead2 predominantly binds to regions
harboring MCAT Tead-binding motifs (Anbanandam et al.,
2006). A closer inspection of Tead2-bound genes and their
changes in gene expression during EMT indicates that Tead2 acts
as a transcriptional activator as well as a repressor. Because Tead
transcription factors lack a transactivation domain, their function
depends on transcriptional co-factors. Thus far, Yap and Taz have
been reported to exclusively act as transcriptional co-activators of
Teads, for example in regulating the expression of the Ctgf and
Cyr61 genes (Zhang et al., 2011; Zhao et al., 2008b). Our analysis
identified new Tead2 target genes like Pard6b and Elmo3, whose
expression are significantly reduced during EMT. The same
promoter regions were also found to be bound by Taz upon
TGFb-treatment, which would implicate that the Tead2–Taz
complex could also function as a transcriptional repressor.
We further report that Taz but not Yap acts as a co-activator
of the Tead2 target gene Zyx. Zyxin protein expression is
upregulated during EMT in a Tead-dependent manner. Zyxin
associates with the actin cytoskeleton and therefore can be
localized at the apical membrane, in focal adhesions and on stress
fibers (Beckerle, 1997). Notably, zyxin is required for the
rearrangement of the actin cytoskeleton during TGFb-induced
EMT of NMuMG cells, thereby enabling cell migration (Mori
et al., 2009). Zyxin upregulation could therefore be at least one of
the mechanisms by which Tead transcriptional activity controls
the induction of a migratory and invasive cellular phenotype
during EMT.
In summary, our results establish a crucial regulatory role
for Tead transcription factors during the process of EMT and
suggest that Teads are not only mere executors of Yap and Taz
functions in promoting EMT and metastasis, but also play a
crucial regulatory role in controlling Yap and Taz subcellular
localization and activity during these processes.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies used were as against the following proteins: actin (Santa Cruz
Biotechnology, Dallas, TX), E-cadherin (BD, San Jose, CA, USA), N-
cadherin (Takara Bio, Otsu, Shiga, Japan), fibronectin (Sigma-Aldrich, St
Louis, MO, USA), GAPDH (Sigma-Aldrich), vimentin (Sigma-Aldrich),
ZO-1 (Zymed, San Francisco, CA), Yap and Taz (Santa Cruz
Biotechnology), Taz (IMGENEX, San Diego, CA, USA), zyxin (Santa
Cruz Biotechnology), HA (Covance, Princeton, NJ, USA). Affinity
purified, polyclonal rabbit anti-Tead2 antibody was generated by
immunizing rabbits with a peptide corresponding to the N-terminus of
Tead2 (amino acids 16–32); phalloidin–Alexa-Fluor-568 was from
Invitrogen (Carlsbad, CA). Reagents used were: recombinant human
TGFb1 (R&D Systems, Minneapolis, MN, USA); Matrigel, growth factor
reduced (BD); Doxycycline (Clontech/Takara).
Cell culture and cell lines
The subclone of NMuMG cells (NMuMG/E9) was as previously
described (Maeda et al., 2005) and was originally obtained from
the American Type Culture Collection (ATCC, Manassas, VA).
MTflEcad and MTDEcad cells and Py2T cells are as described
previously (Lehembre et al., 2008; Waldmeier et al., 2012). All cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with glutamine, penicillin, streptomycin and 10% FBS
(Sigma-Aldrich). Cells were treated with 2 ng/ml TGFb.
Plasmids
The GTIIC reporter was generated by subcloning the GTIIC Tead
response elements including the basal promoter from pd51-LucII (kindly
provided by Hiroshi Sasaki, RIKEN Center for Developmental Biology,
Kobe, Japan) into pGL4 (Promega, Madison, WI, USA) (Davidson et al.,
1988; Ota and Sasaki, 2008). The MCAT reporter was derived from this
construct by replacement of 86GTIIC with eight copies of the sequence
CCTGACACACATTCCTCAGCT (86MCAT), where the MCAT core
motif is underlined, and flanking sequences were according to Larkin
et al. (Larkin et al., 1996). The Cyr61prom WT and Cyr61prom TeadMut
reporters were previously described (Lai et al., 2011) and kindly provided
by Xiaolong Yang (Pathology and Molecular Medicine, Queen’s
University, Ontario, Canada). The Renilla luciferase expressing vector
(pRL-CMV) was from Promega. Murine Tead1-4 in pcDNA3.1 were
kindly provided by Jaime Carvajal (The Institute of Cancer Research,
London, UK). Retroviral Tead2-WT and Tead2-VP16 constructs were as
described previously (Ota and Sasaki, 2008). Retroviral HA-tagged
Tead2, Tead2-VP16, Tead2-EnR, Taz and Yap were created by inserting
the respective cDNAs into the pBabe-derived retroviral vector pRFTO
containing an N-terminal HA tag (kindly provided by Reto Kohler, FMI,
Basel, Switzerland). Original cDNAs were kind gifts from H. Sasaki
(Tead2, Tead2-VP16), R. Kohler (Yap, YapS127A) and Kun-Liang Guan
(Department of Pharmacology and Moores Cancer Center, UCSD, La
Jolla, USA) (Taz, TazS89A). The lentiviral, doxycycline-inducible HA–
Tead2 and HA–Tead2-EnR constructs were generated by subcloning
from pRFTO into pLVX-tight-puro (Clontech, Madison, WI, USA).
Retroviral HA-tagged Tead2 Y440H was generated by PCR-mediated
site-specific mutagenesis.
RNA interference
10 nM siGENOME smart pool siRNAs (Dharmacon, Lafayette, CO,
USA) against murine Tead1, Tead2, Tead3, Tead4, Yap, Taz and Zyxin
were used for transient knockdown experiments. Transfection was
performed with Lipofectamine RNAiMax (Invitrogen) according to the
manufacturer’s instructions.
RNA isolation and RT-PCR
Total RNA was prepared using TriReagent (Sigma-Aldrich), reverse
transcribed with M-MLV reverse transcriptase (Promega), and transcripts
were quantified by PCR using SYBR-green PCR MasterMix (Invitrogen).
Riboprotein L19 primers were used for normalization. PCR assays were
performed in triplicate, and fold induction was calculated using the
comparative Ct method (DD Ct). Primers used for quantitative RT-PCR are
listed in supplementary material Table S3.
Luciferase reporter assay
Cells were plated in triplicate in 24-well plates. At 1 day after plating,
cells were transfected with 800 ng reporter and 10 ng of plasmids
encoding Renilla luciferase using Lipofectamine 2000 (Invitrogen). Cells
were lysed using 16 passive lysis buffer (Promega) and lysates were
analyzed using the Dual-Luciferase reporter assay system (Promega) and
a Berthold Luminometer LB960. Firefly luciferase values were
normalized to internal Renilla luciferase control values.
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Cell fractionation and co-immunoprecipitation
Nuclear and cytoplasmic extracts were prepared with NE-PER nuclear
and cytoplasmic extraction reagents (Thermo Scientific, Waltham,
MA, USA) according to the manufacturer’s instructions. Protein-G-
coupled Dynabeads (Invitrogen) were used for co-immunoprecipitation
experiments on total, nuclear and cytoplasmic cell extracts according to
the manufacturer’s instructions. Samples were analyzed by SDS-PAGE.
Immunoblotting, immunofluorescence staining, retroviral
infection and Affymetrix gene expression profiling
These were performed as described previously (Waldmeier et al., 2012).
Lentiviral infection
Stable pools of cells expressing Tead2-WT or Tead2-EnR in a
doxycycline-inducible fashion were generated using the Lenti-X Tet-
On Advanced system (Clontech). Lentiviral particles were produced
according to the manufacturer’s instructions using the helper vectors
pHDM-HGPM2, pHDM-Tat1b, pRC-CMV-RaII and the envelope-
encoding vector pVSV. For infection, viral supernatants were added to
target cells in the presence of polybrene (8 mg/ml). Cells were spun for 1
hour at 30 C˚ at 1000 g and were subsequently incubated at 37 C˚ under
5% CO2 in a tissue culture incubator for 2 hours. Viral supernatant was
replaced by normal growth medium and after 1 day, antibiotic selection
was performed.
Transwell migration and invasion assay
Trypsinized and washed cells were resuspended in growth medium
containing 0.2% FBS and 2 ng/ml TGFb, where appropriate. 2.56104
cells in 500 ml medium were seeded into cell culture insert chambers
(BD). Bottoms of the chambers contained 700 ml of growth medium
supplemented with 20% FBS. After 24 hours in a tissue culture
incubator at 37 C˚ under 5% CO2, cells were fixed with 4% PFA in
PBS for 10 minutes. Cells that had not crossed the membrane were
removed with a cotton swab, and cells on the bottom of the membrane
were stained with DAPI and quantified using a Leica DMI 4000
microscope.
3D Matrigel culture
Growth factor-reduced Matrigel (BD) was diluted to 4 mg/ml protein
with serum-free growth medium. 2500 cells in 10 ml Matrigel were
transferred to one well of a m-slide angiogenesis microscopy slide (ibidi,
Martinsried, Germany). After 20 minutes of gel solidification in a tissue
culture incubator, 50 ml of normal growth medium was added. Growth
medium was replenished after 3 days. After 5 days of growth, structures
were photographed using a Leica DMIL microscope.
Tail vein injection, tissue processing and H&E staining
0.56106 Py2T cells were injected orthotopically into the tail vein of three
months old female Balb/c nude mice. Mice were killed at 33 days post
injection and lungs were isolated. Tissue processing and H&E staining
were performed as previously described (Waldmeier et al., 2012). All
studies involving mice were approved by the Swiss Federal Veterinary
Office (SFVO) and the regulations of the Cantonal Veterinary Office of
Basel Stadt (licences 1878, 1907, 1908).
Chromatin immunoprecipitation
ChIP experiments were performed as previously described (Weber et al.,
2007). In brief, crosslinked chromatin was sonicated to achieve an
average fragment size of 500 bp. Starting with 150 mg of chromatin and
5 mg of antibody, 1/40 of the ChIP sample and a 1:100 dilution of input
DNA were used for quantitative PCR per reaction. Fold enrichment of
specific target genes was calculated by IP over Input samples and was
normalized to IgG negative control. Primers used for ChIP-qPCR are
listed in supplementary material Table S4.
ChIP-Seq
ChIP libraries were prepared using the ChIP-Seq sample Prep Kit from
Illumina (San Diego, CA, USA) and were sequenced using Illumina
HiSeq 2000 according to the manufacturer’s protocol. ChIP-Seq data
were processed as described (Langmead et al., 2009; Stadler et al., 2011).
Briefly, reads were mapped against the Mus musculus genome (UCSC,
mm9) using bowtie software (version 0.9.9.1) with parameters -v 2 -a -m
100, tracking up to hundred best alignment positions per read and
allowing at most two mismatches. Each alignment was weighted by the
inverse of the number of hits. All quantifications were based on weighted
alignments. Chipcor software (http://sourceforge.net/projects/chip-seq)
was used to estimate the fragment length. Alignments from ChIP-Seq
experiments were shifted by half of the estimated fragment length
towards their 39 end. Clusters of ChIP-Seq read alignments were
identified employing MACS software (v.1.3.7.1) (Zhang et al., 2008)
using IP and input samples with following parameters: nomodel,
gsize52700000000, tsize550, pvalue51e-5 and shiftsize5(chipcor
estimate)/2. Resulting peak candidates were further filtered based on
the enrichment over the input chromatin and only peaks with at least 4-
fold enrichment were used.
Motif analysis
For HOMER analysis, motif detection in the vicinity of Tead2-binding
sites was carried out using the Hypergeometric Optimization of Motif
EnRichment tools (HOMER; v4.1) (Heinz et al., 2010). For PhyloGibbs,
de novo motif generation was used as described previously (Siddharthan
et al., 2005).
Motif activity response analysis
Microarray raw data (.CEL files) were uploaded to http://ismara.unibas.
ch/fcgi/mara for analysis.
Statistical analysis
Statistical analysis and graphs were generated using the GraphPad Prism
software (GraphPad Software Inc.). Statistical analyses were performed
as indicated in figure legends.
Accesssion numbers
Gene expression data of Py2T untreated versus five days TGFb-treated
cells and ChIP-Seq data of Tead2 ChIP during TGFb-induced EMT in
Py2T cells are deposited at Gene Expression Omnibus (GEO accession
number: GSE55711).
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